Clinical Trials Logo

Blood Glucose clinical trials

View clinical trials related to Blood Glucose.

Filter by:
  • Recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06458946 Recruiting - Blood Glucose Clinical Trials

Monitoring Postprandial Blood Glucose and Insulin in Fruit Snacks

Start date: May 22, 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to compare the postprandial glucose and insulin responses after different fruit snacks compared to confection control in a healthy population

NCT ID: NCT05750316 Recruiting - Blood Glucose Clinical Trials

Impact of Consumption of Cowpea Leaves on Blood Glucose

Start date: March 1, 2023
Phase: N/A
Study type: Interventional

Intake of foods high in carbohydrates causes a spike in glucose in the blood. Repeated high blood glucose spikes are associated with an increased risk of diabetes. Polyphenols, which are abundant in vegetables, may influence how the body utilises carbohydrates. Cowpea, also referred to as black-eyed peas (Vigna unguiculata (L.) Walp.) leaves, contain polyphenols and fibre that can help regulate blood glucose. The study will be an acute, single-blind, randomised control trial with a cross-over design involving healthy black participants aged ≥18 years. This clinical trial aims to investigate if consuming cowpea leaves can reduce blood glucose spikes after consuming a meal high in carbohydrates. Participants will be randomised to consume either bread with jam containing freeze-dried cowpea leaves (active intervention) or jam without any freeze-dried powder (control group). Blood glucose will be monitored before the intervention and every 15 minutes after the intervention using a continuous glucose monitor.

NCT ID: NCT05585801 Recruiting - Critical Care Clinical Trials

Continuous Glucose Monitoring in Intensive Care Unit

Start date: November 1, 2022
Phase: N/A
Study type: Interventional

Glucose control in ICU patients is challenging and exerts high burden on the nursing staff. Continuous glucose monitors (CGM) are now approved and widely available in the outpatient setting for patients with diabetes mellitus. However, only minimal evidence on CGM performance, reliability and benefit in achieving desired glucose control in the intensive care setting has been gathered so far. The objective of this study is to assess whether the use of CGM helps to maintain blood glucose levels within the time in range recommended for patients in the intensive care. In addition, accuracy of the sensor will be evaluated and compared to measurements of blood glucose by standardized biochemistry methods.

NCT ID: NCT05397509 Recruiting - Blood Glucose Clinical Trials

Effect of the Olive Leaf Tea Ingestion in Post-prandial Glycemic Response (OLIFTEA)

OLIFTEA
Start date: April 29, 2022
Phase: N/A
Study type: Interventional

This study tests the effect of Olive Tea Ingestion in ameliorating glycemic response after a high-glycemic meal

NCT ID: NCT05273411 Recruiting - Ketosis Clinical Trials

The Effect of Different Ketone Supplements on Blood β-OHB and Blood Glucose in Healthy Individuals

Start date: March 24, 2022
Phase: N/A
Study type: Interventional

Ketone bodies are a fuel source and signaling molecule that are produced by your body during prolonged fasting or if you consistently eat at low-carbohydrate diet. Blood ketones can be used as a source of energy during fasting and are used by your brain as an alternative source of fuel to glucose. Previous studies have found that ketones, when consumed in form of a supplement drink, can increase blood ketone levels and lower blood glucose, the amount of sugar in your blood. This is of potential interest for individuals with high blood sugar, such as people living with type 2 diabetes. However, there are different types of ketone supplements that differ in how they are metabolized in the body. Little is known about how these supplements affect blood ketone and blood glucose levels. The main objective of this study is to determine the effect of three different ketone supplements on blood ketones and blood glucose. The results of this pilot study will be used to guide future research for larger and more extensive studies on ketone supplements.

NCT ID: NCT05255783 Recruiting - Critical Care Clinical Trials

The Performance of Dexcom G6 Glucose Monitoring in Critically Ill Patients

Start date: November 19, 2021
Phase: N/A
Study type: Interventional

This is an investigator-initiated, prospective, observational accuracy-study. The aim of the study is to test the feasibility, safety, and accuracy of a subcutaneous continuous glucose monitoring system (the Dexcom G6 glucose monitoring system) in critically ill patients. A total of 40 adult patients admitted to the intensive care unit requiring intravenous insulin infusion to maintain blood glucose within target range will be enrolled. Subcutaneous glucose readings will be compared with routine arterial blood glucose measurements to determine accuracy.

NCT ID: NCT04989712 Recruiting - Cognitive Change Clinical Trials

MOReS Freestyle Libre Validation Study

Start date: October 28, 2021
Phase: N/A
Study type: Interventional

To measure the effects of interrupting prolonged sitting with brief standing physical activity interventions on physical and cognitive performance, health and wellbeing in young people.

NCT ID: NCT04935957 Recruiting - Blood Glucose Clinical Trials

Study of GLUCUBE Performance, a Non-invasive System for Monitoring Blood Glucose Levels Based on Near Infrared Spectroscopy (NIRS) Technology.

Start date: March 11, 2024
Phase: N/A
Study type: Interventional

This study is a prospective, single center, non-interventional, open label clinical investigation. The primary objective of the study is to evaluate the performance of GLUCUBE system compared to the standard glucometer in the determination of blood glucose level in adult patients.

NCT ID: NCT04930276 Recruiting - Microbiota Clinical Trials

Diet-glucose-gut Microbiome Net in Women With GDM

Start date: March 5, 2021
Phase: N/A
Study type: Interventional

A prospective cohort study was conducted to :1. explore the effective of diet intervention on blood glucose control; 2. observe the changeable composition of microbiota; 3. seek the possible microbiome intervened to prevent GDM.

NCT ID: NCT04578067 Recruiting - Physical Activity Clinical Trials

Empowering Immigrant Women for Active and Healthy Lifestyle

Start date: September 30, 2020
Phase: N/A
Study type: Interventional

The study will include overweight and obese otherwise healthy women, recruited from two main borough in Oslo with the highest population of Somali origin. The study comprises two phases: A 12-months controlled trial where the participants in the intervention borough will be compared to participants in the control borough. This is followed by a 12-months maintaining phase for the intervention borough where the control group will be given the same intervention as the intervention group received during the first 12-months.